India, May 14 -- US-based Illumina Inc. hasannounced the launch of DRAGEN version 4.4 software (v4.4), the industry's most comprehensive secondary analysis solution. The latest version of DRAGEN includes out-of-the-box oncology applications for clinical research and support for newly announced Illumina multiomics assays.

Additionally, DRAGEN v4.4 continues DRAGEN's best-in-class accuracy with a 30% improvement in germline structural variant calling accuracy.DRAGEN v4.4 enhancements will simplifynext-generation sequencing NGS analysis for customers while expanding their capabilities.

Providing labs with ready-to-use analysis applications simplifies oncology biomarker detection and reduces complexities for customers. The applications inte...